Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 11UNKNOWN 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Breast Neoplasms 1Brain Neoplasms 1

Interventions

Paclitaxel 6Radiotherapy 3Epirubicin 3Radiotherapy, Intensity-Modulated 2Radiation Dose Hypofractionation 2Radiation 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Capecitabine 2pegylated granulocyte colony-stimulating factor 1nabiximols 1aumolertinib 1Zoledronic Acid 1Vinorelbine 1Temozolomide 1TP protocol 1Standard of Care 1S 1 (combination) 1Platinum 1Pemetrexed 1Neoadjuvant Therapy 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Drug Therapy 1Decitabine 1Chemotherapy, Adjuvant 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Radiation Dose Hypofractionation × Clear all
NCT03778541 2019-07-23

HFSRT With Concurrent TMZ for Large BMs

ChineseAMS

Phase 3 Unknown
224 enrolled
CNS

Brain Neoplasms

NCT00793962 2018-10-11

A Phase â…¢ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

ChineseAMS

Phase 3 Completed
810 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡